Skip to main content
. 2011 Feb 14;286(14):11895–11908. doi: 10.1074/jbc.M110.200436

TABLE 2.

Activity profile of FPA and SPA for PPARγ

IC50 values were determined using data from two independent experiments in triplicate. ND, not determined.

Compound FPA: IC50vs. DRIP-2 SPA: IC50vs. [3H]rosiglitazone
GW9662 ND 0.13 ± 0.01
Rosiglitazone 0.8 ± 0.2 0.48 ± 0.04
17 15 ± 1.7 1.7 ± 0.3